Evolus (EOLS) EBIT Margin (2019 - 2026)
Evolus' EBIT Margin came in at -5.40% for Q2 2026, up 9.31 percentage points from -14.71% a year earlier and up 3.96 percentage points from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) EBIT Margin (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Evolus reported EBIT Margin of -5.90%, up 9.63 percentage points year-over-year; for FY2025, it was -10.99%, up 1.93 percentage points from FY2024.
- EBIT Margin has increased in each of the last six years, with a five-year change of +259.73 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was -12.92% in FY2024 (+11.44 pp), -24.36% in FY2023 (+19.60 pp), -43.96% in FY2022 (+0.59 pp) and -44.55% in FY2021 (+226.17 pp).
- The five-year range for quarterly EBIT Margin is -71.63% (Q3 2021) to 4.67% (Q4 2025).
- Year-over-year, EBIT Margin has increased for four consecutive quarters, with an average year-over-year change of +5.10 percentage points over the last eight quarters.
- The fastest year-over-year change in EBIT Margin over five years came in Q4 2021 (a gain of 472.97 percentage points), and the weakest in Q1 2022 (a drop of 111.13 percentage points).
- Business Quant data shows EOLS's EBIT Margin at -9.36% (Q1 2026), 4.67% (Q4 2025) and -16.67% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Evolus | 525.47 Mn | 333.16 Mn | 57.18 Mn | -5.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.40% |
| Mar 31, 2026 | -9.36% |
| Dec 31, 2025 | 4.67% |
| Sep 30, 2025 | -16.67% |
| Jun 30, 2025 | -14.71% |
| Mar 31, 2025 | -22.14% |
| Dec 31, 2024 | -2.93% |
| Sep 30, 2024 | -25.33% |
| Jun 30, 2024 | -11.51% |
| Mar 31, 2024 | -15.04% |
| Dec 31, 2023 | -14.16% |
| Sep 30, 2023 | -26.87% |
| Jun 30, 2023 | -30.64% |
| Mar 31, 2023 | -28.86% |
| Dec 31, 2022 | -24.37% |
| Sep 30, 2022 | -52.80% |
| Jun 30, 2022 | -57.44% |
| Mar 31, 2022 | -45.56% |
| Dec 31, 2021 | -52.02% |
| Sep 30, 2021 | -71.63% |
API Access
Evolus EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();